Oramed Pharmaceuticals Presents Data from Phase IIa Trial with ORMD-0801 at the 2014 Diabetes Summit
April 24, 2014 at 14:31 PM EDT
Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of ...